A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)
Author Type(s)
Faculty, Resident/Fellow
Document Type
Abstract
Publication Date
11-15-2022
Journal Title
Blood
Department
Pediatrics
Second Department
Medicine
Third Department
Public Health
Recommended Citation
Schaefer, E., Kanarfogel, T., Hochberg, J. C., Thatcher, E., Klejmont, L., Chu, Y. Y., Shi, Q. H., Dozer, A. J., Friedman, D., Mahanti, H., Morris, E., Fabricatore, S., DeFresne, J., Cooke, K. R., & Cairo, M. S. (2022). A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812). Blood, 140, 2532-2534. https://doi.org/10.1182/blood-2022-168299